| NCT00001012 |
|
A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes
|
View
|
| NCT00001011 |
|
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
|
View
|
| NCT00001010 |
|
A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
|
View
|
| NCT00001009 |
|
A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex ARC
|
View
|
| NCT00001008 |
|
A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex ARC
|
View
|
| NCT00001007 |
|
A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
|
View
|
| NCT00001006 |
|
A Study of AS-101 in Patients With AIDS or AIDS Related Complex ARC
|
View
|
| NCT00001005 |
|
A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
|
View
|
| NCT00001004 |
|
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
|
View
|
| NCT00001003 |
|
A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
|
View
|
| NCT00001002 |
|
A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
|
View
|
| NCT00001001 |
|
A Study of Zidovudine in HIV-Infected Patients With Liver Disease
|
View
|
| NCT00001000 |
|
A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection
|
View
|
| NCT00000999 |
|
The Safety and Effectiveness of Zidovudine AZT in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
|
View
|
| NCT00000998 |
|
A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia PCP in Patients With AIDS Not Previously Treated for PCP
|
View
|
| NCT00000997 |
|
A Study of Dideoxycytidine in HIV-Infected Patients
|
View
|
| NCT00000996 |
|
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposis Sarcoma
|
View
|
| NCT00000995 |
|
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus CMV Infection
|
View
|
| NCT00000994 |
|
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposis Sarcoma
|
View
|
| NCT00000993 |
|
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
|
View
|
| NCT00000992 |
|
A Study of Itraconazole in Preventing the Return of Histoplasmosis a Fungal Infection in Patients With AIDS
|
View
|
| NCT00000991 |
|
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
|
View
|
| NCT00000990 |
|
The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
|
View
|
| NCT00000989 |
|
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus CMV of the Eye in Patients With AIDS
|
View
|
| NCT00000988 |
|
A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex
|
View
|
| NCT00000987 |
|
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposis Sarcoma in Patients With AIDS
|
View
|
| NCT00000986 |
|
The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex
|
View
|
| NCT00000985 |
|
Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
|
View
|
| NCT00000984 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Infants and Children Infected With or at Risk for HIV Infection
|
View
|
| NCT00000983 |
|
The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
|
View
|
| NCT00000982 |
|
A Study of Azidothymidine in HIV-Infected Children
|
View
|
| NCT00000981 |
|
The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus CMV in Patients With AIDS
|
View
|
| NCT00000980 |
|
A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
|
View
|
| NCT00000979 |
|
Comparison of ddI Versus Zidovudine in HIV-Infected Patients
|
View
|
| NCT00000978 |
|
A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex ARC
|
View
|
| NCT00000977 |
|
Active Immunization of Asymptomatic HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen A Phase III Study of Immunogenicity and Toxicity
|
View
|
| NCT00000976 |
|
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G rCD4-IgG Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
|
View
|
| NCT00000975 |
|
A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis a Fungal Infection in Patients With AIDS
|
View
|
| NCT00000974 |
|
A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia
|
View
|
| NCT00000973 |
|
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
|
View
|
| NCT00000972 |
|
A Phase I Clinical Trial to Evaluate Part A The Safety of MTP-PEMF59 Adjuvant Emulsion Part B The Safety and Immunogenicity of Env 2-3 a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1 in Combination With MTP-PEMF59
|
View
|
| NCT00000971 |
|
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex MAC Infections in Children With AIDS
|
View
|
| NCT00000970 |
|
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir
|
View
|
| NCT00000969 |
|
A Prospective Randomized Open-Label Comparative Trial of Dideoxyinosine ddI Versus Dideoxycytidine ddC in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine AZT Therapy
|
View
|
| NCT00000968 |
|
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein gp160
|
View
|
| NCT00000967 |
|
The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
|
View
|
| NCT00000966 |
|
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
|
View
|
| NCT00000965 |
|
The Effects of Zidovudine on the Blood of HIV-Infected Patients
|
View
|
| NCT00000964 |
|
The Effect of Stomach Acid on Foscarnet
|
View
|
| NCT00000963 |
|
A Study of Dideoxyinosine ddI in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
|
View
|
| NCT00000962 |
|
The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
|
View
|
| NCT00000961 |
|
The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin HVIG Plus Zidovudine in HIV-Infected Infants
|
View
|
| NCT00000960 |
|
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
|
View
|
| NCT00000959 |
|
Prophylaxis Against Tuberculosis TB in Patients With Human Immunodeficiency Virus HIV Infection and Suspected Latent Tuberculous Infection
|
View
|
| NCT00000958 |
|
A Placebo-Controlled Phase I Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3 a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1 in Combination With MTP-PEMF59 in Individuals With HIV Infection Placebo Patients Receive MF59 Emulsion Only
|
View
|
| NCT00000957 |
|
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein gp160 of Human Immunodeficiency Virus Evaluation of Accelerated Schedules
|
View
|
| NCT00000956 |
|
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
|
View
|
| NCT00000955 |
|
Two-Stage Tuberculin PPD Skin Testing in Individuals With Human Immunodeficiency Virus HIV Infection
|
View
|
| NCT00000954 |
|
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposis Sarcoma
|
View
|
| NCT00000953 |
|
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients
|
View
|
| NCT00000952 |
|
A Study of Ritonavir an Anti-HIV Drug in HIV-Positive Infants and Children
|
View
|
| NCT00000951 |
|
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
|
View
|
| NCT00000950 |
|
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
|
View
|
| NCT00000949 |
|
A Study to Evaluate the Effects of Giving Proleukin rIL-2 to HIV-Positive Patients With CD4 Counts Greater Than 300 Cellsmm3
|
View
|
| NCT00000948 |
|
Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
| NCT00000947 |
|
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
|
View
|
| NCT00000946 |
|
A Study to Test the Safety of Three Experimental HIV Vaccines
|
View
|
| NCT00000945 |
|
A Study to Evaluate the Use of Cidofovir an Experimental Drug for the Treatment of Progressive Multifocal Leukoencephalopathy PML in AIDS Patients
|
View
|
| NCT00000944 |
|
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy Indinavir Lamivudine and Zidovudine in HIV-Positive Pregnant Women and Their Infants
|
View
|
| NCT00000943 |
|
A Study to Test If Giving Remune an HIV Vaccine Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
|
View
|
| NCT00000942 |
|
A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
|
View
|
| NCT00000941 |
|
A Study on Possible Interactions Between Protease Inhibitors Anti-HIV Drugs and Drugs Which Lower the Level of Fat in Your Blood
|
View
|
| NCT00000940 |
|
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
|
View
|
| NCT00000939 |
|
A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible
|
View
|
| NCT00000938 |
|
A Randomized Double-Blind Placebo-Controlled Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
|
View
|
| NCT00000937 |
|
Study and Treatment of Post Lyme Disease STOP-LD
|
View
|
| NCT00000936 |
|
A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
|
View
|
| NCT00000935 |
|
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
|
View
|
| NCT00000933 |
|
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients A Substudy of CPCRA 048
|
View
|
| NCT00000932 |
|
A Study of the Long-Term Outcomes of HIV-Positive Patients
|
View
|
| NCT00000931 |
|
HIV Prevention Counseling for Men Who Have Sex With Men
|
View
|
| NCT00000930 |
|
A Study of HIV in Newly Infected Individuals
|
View
|
| NCT00000929 |
|
A Study of the Effects of Advantage 24 on the Rectum
|
View
|
| NCT00000928 |
|
Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples
|
View
|
| NCT00000927 |
|
A Study of BufferGel in Women
|
View
|
| NCT00000926 |
|
A Study of Nonoxynol-9 N-9 and HIV Infection
|
View
|
| NCT00000925 |
|
A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
|
View
|
| NCT00000924 |
|
A Study to Compare Two Different Anti-HIV Drug Regimens
|
View
|
| NCT00000923 |
|
Treatment With Interleukin-2 IL-2 Plus Combination Anti-HIV-Drug Therapy HAART for Patients Formerly in ACTG 328
|
View
|
| NCT00000922 |
|
A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy HAART
|
View
|
| NCT00000921 |
|
The Effects of Prednisone on HIV Levels and the Immune System
|
View
|
| NCT00000920 |
|
Fortovase Saquinavir Given With Low-Dose Ritonavir Zidovudine and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
|
View
|
| NCT00000919 |
|
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
|
View
|
| NCT00000918 |
|
A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir an Anti-HIV DrugTreatment Failure
|
View
|
| NCT00000917 |
|
Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
|
View
|
| NCT00000916 |
|
A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copiesml of HIV RNA in Their Blood
|
View
|
| NCT00000915 |
|
An HIV Vaccine Preparedness Study
|
View
|
| NCT00000914 |
|
A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
|
View
|
| NCT00000913 |
|
A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
|
View
|
| NCT00000912 |
|
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
|
View
|
| NCT00000911 |
|
A Study to Monitor Patients With Primary or Early HIV Infection
|
View
|
| NCT00000910 |
|
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
|
View
|
| NCT00000909 |
|
A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3 Who Do Not Wish to Receive Anti-HIV Therapy
|
View
|
| NCT00000908 |
|
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
|
View
|
| NCT00000907 |
|
A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex DMAC in HIV-Positive Patients
|
View
|
| NCT00000906 |
|
Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients
|
View
|
| NCT00000905 |
|
A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus CMV Retinitis After Effective Anti-HIV Therapy
|
View
|
| NCT00000904 |
|
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
|
View
|
| NCT00000903 |
|
Addition of Efavirenz or Nelfinavir to a LamivudineZidovudineIndinavir HIV Treatment Regimen
|
View
|
| NCT00000902 |
|
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
|
View
|
| NCT00000901 |
|
Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
|
View
|
| NCT00000900 |
|
The Effects of Illnesses on HIV Levels in the Body
|
View
|
| NCT00000899 |
|
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
|
View
|
| NCT00000898 |
|
The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir Ritonavir and Saquinavir
|
View
|
| NCT00000897 |
|
A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine an Anti-HIV Drug in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women
|
View
|
| NCT00000896 |
|
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
|
View
|
| NCT00000895 |
|
A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
|
View
|
| NCT00000894 |
|
Comparison of Two Drugs Cidofovir and Ganciclovir in Treating Patients With AIDS Who Have CMV Retinitis
|
View
|
| NCT00000893 |
|
Safety Tolerability and Anti-HIV Activity of DMP 266 Efavirenz in Combination With Nelfinavir in HIV-Positive Children
|
View
|
| NCT00000892 |
|
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
|
View
|
| NCT00000891 |
|
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy HAART in Subjects With Moderately Advanced HIV-1 Disease A Follow-Up Study to ACTG 315
|
View
|
| NCT00000890 |
|
A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue Muscle in HIV-Positive Patients
|
View
|
| NCT00000889 |
|
A Study to Evaluate the Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
| NCT00000888 |
|
Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies
|
View
|
| NCT00000887 |
|
A Study to Evaluate the Safety and Tolerance of Nelfinavir NFV Given With Zidovudine ZDV and Lamivudine 3TC in HIV-Positive Pregnant Women and Their Infants
|
View
|
| NCT00000886 |
|
A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate IFA
|
View
|
| NCT00000885 |
|
Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs A Rollover Study for ACTG 320
|
View
|
| NCT00000884 |
|
A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers
|
View
|
| NCT00000883 |
|
Long-Term Assessment for Metabolic Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
|
View
|
| NCT00000882 |
|
Virologic and Immunologic Activity of Continued Lamivudine 3TC vs Delavirdine DLV in Combination With Indinavir IDV and Zidovudine ZDV or Stavudine d4T in 3TC-Experienced Subjects
|
View
|
| NCT00000881 |
|
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus CMV Disease
|
View
|
| NCT00000880 |
|
A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
|
View
|
| NCT00000879 |
|
A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
|
View
|
| NCT00000878 |
|
A Study to Evaluate the Safety and Tolerance of Stavudine d4T in Combination With Lamivudine 3TC in HIV-Positive Pregnant Women and Their Infants
|
View
|
| NCT00000877 |
|
Study of How Indinavir an Anti-HIV Drug and Rifabutin a Drug Used to Treat MAC an HIV-Associated Disease Interact in HIV-Positive and HIV-Negative Adults
|
View
|
| NCT00000876 |
|
Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
|
View
|
| NCT00000875 |
|
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte CTL Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
|
View
|
| NCT00000874 |
|
A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing GART Compared With Antiretroviral Management Without Plasma GART
|
View
|
| NCT00000873 |
|
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
|
View
|
| NCT00000872 |
|
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
|
View
|
| NCT00000871 |
|
A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
|
View
|
| NCT00000870 |
|
A Phase II Study of Intermittent Recombinant Human Interleukin-2 rhIL-2 by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy HAART Compared to HAART Alone
|
View
|
| NCT00000869 |
|
A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
|
View
|
| NCT00000868 |
|
A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 an HIV Vaccine Given With or Without HIV-1 MN rgp120 Another HIV Vaccine to HIV-Negative Volunteers
|
View
|
| NCT00000867 |
|
A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex ADC
|
View
|
| NCT00000866 |
|
A Multicenter Randomized Placebo-Controlled Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENVGAGPOL Vaccine TCB-3B and MN RGP 120HIV-1 In Alum
|
View
|
| NCT00000865 |
|
The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children
|
View
|
| NCT00000864 |
|
A Study to Test the Safety Tolerance and Metabolism of Abacavir 1592U89 ABC With Standard Zidovudine ZDV Therapy in Newborn Infants Born to HIV-1 Infected Women
|
View
|
| NCT00000863 |
|
A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia PCP in HIV-Infected Patients
|
View
|
| NCT00000862 |
|
A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
|
View
|
| NCT00000861 |
|
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
|
View
|
| NCT00000860 |
|
The Effects of Treatment for Mycobacterium Avium Complex MAC on the Cells of HIV-Infected Patients
|
View
|
| NCT00000859 |
|
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral AR Nucleoside Therapy in HIV-Infected Individuals With CD4 Cell Counts Less Than or Equal to 200mm3
|
View
|
| NCT00000858 |
|
Detection of Human Immunodeficiency Virus Type 1 HIV-1 in Vaginocervical Secretions Correlation With Clinical Status Virologic and Immunologic Parameters and the Presence of Other Infections
|
View
|
| NCT00000857 |
|
A Study to Evaluate the Effects of Interleukin-12 rhIL-12 in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cellsmm3 or 300-500 Cellsmm3
|
View
|
| NCT00000856 |
|
A Phase III Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease
|
View
|
| NCT00000855 |
|
A Study to Evaluate the Safety and Tolerability of Zidovudine ZDV in Premature Infants Born to HIV-Positive Women
|
View
|
| NCT00000854 |
|
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
|
View
|
| NCT00000853 |
|
A Phase I Multicenter Randomized Double-Blind Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120HIV-1 Genentech in Combination With QS21 Adjuvant or Alum in Healthy Adults
|
View
|
| NCT00000852 |
|
A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
|
View
|
| NCT00000851 |
|
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
|
View
|
| NCT00000850 |
|
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
|
View
|
| NCT00000849 |
|
A Study to Test the Safety of Recombinant Interleukin-2 rIL-2 in HIV-Infected Children
|
View
|
| NCT00000848 |
|
The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year
|
View
|
| NCT00000847 |
|
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers
|
View
|
| NCT00000846 |
|
A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen Given by IM Injection in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally in HIV-1 Uninfected Volunteers
|
View
|
| NCT00000845 |
|
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects
|
View
|
| NCT00000844 |
|
A Multicenter Prospective Randomized Double-Blind Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4 Counts 50 and 350 Cellsmm3
|
View
|
| NCT00000843 |
|
The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children
|
View
|
| NCT00000842 |
|
A Phase II Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
|
View
|
| NCT00000841 |
|
A Study of Indinavir Sulfate Plus Zidovudine AZT Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
|
View
|
| NCT00000840 |
|
A Multicenter Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA
|
View
|
| NCT00000839 |
|
A Phase I Trial to Evaluate Didanosine ddI in HIV-Infected Pregnant Women
|
View
|
| NCT00000838 |
|
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine Stavudine or Didanosine
|
View
|
| NCT00000837 |
|
A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
|
View
|
| NCT00000836 |
|
A Phase IIIII Trial of Human Anti-CMV Monoclonal Antibody MSL 109 MACRT
|
View
|
| NCT00000835 |
|
A Multicenter Randomized Placebo-Controlled Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine
|
View
|
| NCT00000834 |
|
A Phase I Study of Methotrexate for HIV Infection
|
View
|
| NCT00000833 |
|
A Phase I Study of Combination Therapy With Didanosine ddI and Ribavirin in HIV-Infected Children
|
View
|
| NCT00000832 |
|
A Randomized Placebo-Controlled Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein HIV-1 SF-2 rgp120 BIOCINE Combined With MF59 in HIV-1 Uninfected Adult Volunteers
|
View
|
| NCT00000831 |
|
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
|
View
|
| NCT00000830 |
|
Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells
|
View
|
| NCT00000829 |
|
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
|
View
|
| NCT00000828 |
|
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
|
View
|
| NCT00000827 |
|
A Phase III Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
|
View
|
| NCT00000826 |
|
Effect of Fluconazole Clarithromycin and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
|
View
|
| NCT00000825 |
|
The Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
|
View
|
| NCT00000824 |
|
A Study of Cytotoxic T Lymphocyte CTL Therapy in HIV-Infected Patients
|
View
|
| NCT00000823 |
|
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various ZidovudineDidanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
|
View
|
| NCT00000822 |
|
A Phase III Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500mm3 CD4 T Cells and 200-400mm3 CD4 T Cells
|
View
|
| NCT00000821 |
|
Subcutaneously Administered Aldesleukin Interleukin-2 IL-2 Therapy in HIV-Infected Patients
|
View
|
| NCT00000820 |
|
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
|
View
|
| NCT00000819 |
|
A Phase II Randomized Double-Blind Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy HIVAN
|
View
|
| NCT00000818 |
|
Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine AZT Treatment in HIV-1-Infected Patients With CD4 Cells Between 100 and 500 Cellsmm3
|
View
|
| NCT00000817 |
|
The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
|
View
|
| NCT00000816 |
|
Gradual Initiation of SulfamethoxazoleTrimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
|
View
|
| NCT00000815 |
|
A Phase II Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
|
View
|
| NCT00000814 |
|
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
|
View
|
| NCT00000813 |
|
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN ALVAC vCP125 HIV-1 gp160 MN in HIV-1 Uninfected Adult Volunteers
|
View
|
| NCT00000812 |
|
A Phase I Placebo-Controlled Dose-Escalation Study of the Safety Tolerability and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
|
View
|
